Shanghai, China

Hu Ge

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Hu Ge: Innovator in Antibody Development

Introduction

Hu Ge is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biotechnology. He holds a total of eight patents, showcasing his innovative work in developing therapeutic antibodies.

Latest Patents

Among his latest patents is the "Anti-PD-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof." This invention provides a humanized anti-PD-1 antibody that contains a specific CDR region, along with its pharmaceutical applications for treating PD-1 associated diseases or disorders. Another notable patent is the "Anti-Claudin 18.2 antibody and application thereof," which relates to an anti-Claudin 18.2 antibody and its various forms, including mouse-derived, chimeric, and humanized antibodies. This invention also outlines its use in preparing drugs for treating Claudin 18.2 positive diseases or disorders.

Career Highlights

Hu Ge has worked with notable companies such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has significantly advanced the development of innovative medical therapies.

Collaborations

Some of his notable coworkers include Weikang Tao and Hua Ying, who have collaborated with him on various projects in the field of biotechnology.

Conclusion

Hu Ge's contributions to antibody development and his innovative patents highlight his role as a key figure in the biotechnology industry. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…